| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | AKOS AU36-M450 | AKOS AU36-M450 | |||
| 2 | 141750-63-2 | Pitavastatin Lactone | Pitavastatin Lactone PITAVASTATIN LACTONE Pivastatin lactone impurity (4R,6S)-6-((E)-2-(2-cyclopropyl Pitavastatin calcium impurity D Pitavastatin Lactone DISCONTINUED (4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]vinyl]tetrahydro-4-hydroxypyran-2-one 4H-Pyrazolo[3,4-d][1,3]thiazin-6-amine, 1-(4-chlorobenzoyl)-4-(4-hydroxy-3-methoxyphenyl)-3-methyl- 4-(1-(4-Chlorobenzoyl)-6-imino-3-methyl-1,4,6,7-tetrahydropyrazolo[3,4-d][1,3]thiazin-4-yl)-2-methoxyphenol (4R,6S,E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl-ethenylvinyl]-4-hydroxyl-3,4,5,6-H-2H-pyran-2-etone [6-amino-4-(4-hydroxy-3-methoxyphenyl)-3-methylpyrazolo[3,4-d][1,3]thiazin-1(4H)-yl](4-chlorophenyl)methanone Pitavastatin calcium intermediates to 5,(4R,6S,E)-6-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinoline-yl-vinyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one Pitavastatin calciuM interMediates to 5, (4R, 6S, E) -6 - [2 - cyclopropyl-4 - (4 - fluorophenyl) -3 - quinoline - yl - vinyl] -4 - hydroxy -3,4,5,6 - tetrahydro-2H-pyran-2 - one | ||
| 3 | Pitavastatin-d5 Lactone | Pitavastatin-d5 Lactone (4R,6S)-6-[(1E)-2-[2-(Cyclopropyl-d5)-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one [4R-[4α,6β(E)]]-6-[2-[2-(Cyclopropyl-d5)-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one Nisvastatin-d5 NK 104-d5 NK 104-d5 (lactone) P 872441-d5 | |||
| 4 | 1661064-71-6 | Pitavastatin Impurity 60 | Pitavastatin Impurity 60 Monocalciumbis[(S,2Z,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-5-hydroxyhepta-2,6-dienoate] | ||
| 5 | 1422058-54-5 | Pitavastatin IMpurity 4 (PP-4) | Pitavastatin Impurity Pitavastatin IMpurity 4 (PP-4) 3,6-Heptadienoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-, (5S,6E)- | ||
| 6 | 338749-03-4 | 1-[2-((4-FLUOROPHENYL)([(4-METHOXYBENZOYL)OXY]IMINO)METHYL)CYCLOPROPYL]-4-METHYLBENZENE | N-((4-FLUOROPHENYL)[2-(4-METHYLPHENYL)CYCLOPROPYL]METHYLENE)-N-[(4-METHOXYBENZOYL)OXY]AMINE 1-[2-((4-FLUOROPHENYL)([(4-METHOXYBENZOYL)OXY]IMINO)METHYL)CYCLOPROPYL]-4-METHYLBENZENE (Z)-[(4-fluorophenyl)[2-(4-methylphenyl)cyclopropyl]methylidene]amino 4-methoxybenzoate | ||
| 7 | 3-[2-(4-fluorophenyl)-2-oxoethyl]-3-hydroxy-1-(3-phenylpropyl)-1,3-dihydro-2H-indol-2-one | 3-[2-(4-fluorophenyl)-2-oxoethyl]-3-hydroxy-1-(3-phenylpropyl)-1,3-dihydro-2H-indol-2-one | |||
| 8 | 2452383-21-8 | 2,6-Heptadienoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-, (2E,5S,6E)- | 2,6-Heptadienoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-, (2E,5S,6E)- Pitavastatin Impurity 47 |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|